Common Bacterial Skin Infections
Common Bacterial Skin Infections
Family physicians frequently treat bacterial skin infections in the office and in the hospi-
tal. Common skin infections include cellulitis, erysipelas, impetigo, folliculitis, and furun-
cles and carbuncles. Cellulitis is an infection of the dermis and subcutaneous tissue that
has poorly demarcated borders and is usually caused by Streptococcus or Staphylococcus
species. Erysipelas is a superficial form of cellulitis with sharply demarcated borders and
is caused almost exclusively by Streptococcus. Impetigo is also caused by Streptococcus or
Staphylococcus and can lead to lifting of the stratum corneum resulting in the commonly
seen bullous effect. Folliculitis is an inflammation of the hair follicles. When the infection
is bacterial rather than mechanical in nature, it is most commonly caused by Staphylo-
coccus. If the infection of the follicle is deeper and involves more follicles, it moves into
the furuncle and carbuncle stages and usually requires incision and drainage. All of these
infections are typically diagnosed by clinical presentation and treated empirically. If
antibiotics are required, one that is active against gram-positive organisms such as peni-
cillinase-resistant penicillins, cephalosporins, macrolides, or fluoroquinolones should be
chosen. Children, patients who have diabetes, or patients who have immunodeficiencies
are more susceptible to gram-negative infections and may require treatment with a sec-
ond- or third-generation cephalosporin. (Am Fam Physician 2002;66:119-24. Copyright©
2002 American Academy of Family Physicians.)
B
This article is one in a acterial skin infections are the Lake City). Knowledge of the presentation,
series coordinated by 28th most common diagnosis in histopathology, and microbiology for each type
Daniel L. Sulberg,
hospitalized patients.1 Cellulitis, of infection is important for proper care of the
M.D., director of
dermatology curricu- impetigo, and folliculitis are the patient. The presentation, etiology, and current
lum at the Utah Valley most common bacterial skin management of these diseases are presented.
Family Practice Resi- infections seen by the family physician. The
dency, Provo, Utah. percentage of office visits for cellulitis was 2.2 Cellulitis
percent, and for impetigo, it was 0.3 percent, in Cellulitis is a painful, erythematous infec-
a cohort of almost 320,000 health plan mem- tion of the dermis and subcutaneous tissues
bers (data taken from primary physician diag- that is characterized by warmth, edema, and
nosis codes from January 1, 1999 to December advancing borders (Table 1). Cellulitis com-
1, 1999 for Intermountain Health Care, Salt monly occurs near breaks in the skin, such as
surgical wounds, trauma, tinea infections
(Figure 1), or ulcerations, but occasionally
TABLE 1
Descriptions of Bacterial Skin Infections
Disease Description
JULY 1, 2002 / VOLUME 66, NUMBER 1 www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 119
Marking the margins of erythema with ink is helpful in
following the progression or regression of cellulitis.
120 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 66, NUMBER 1 / JULY 1, 2002
Skin Infections
Erysipelas
Erysipelas (Figure 3), also known as St.
Anthony’s fire, usually presents as an intensely
erythematous infection with clearly demar-
cated raised margins, and often with associated
FIGURE 3. Erysipelas. lymphatic streaking (Table 1). Common sites
are the legs and face.15 Most cases do not have
an inciting wound or skin lesion and are pre-
ceded by influenza-like symptoms. The inci-
dence of erysipelas is rising, especially in young
children, the elderly, persons with diabetes,
alcoholic persons, and patients with compro-
mised immune systems or lymphedema.6
Erysipelas is caused almost exclusively by
beta-hemolytic streptococcus and thus can be
treated with standard dosages of oral or intra-
venous penicillin. However, most physicians
treat this infection the same as cellulitis, which
is outlined earlier. Adjunctive treatment and
FIGURE 4. Nonbullous impetigo. complications are the same as for cellulitis.
Impetigo
Impetigo is most commonly seen in chil-
dren aged two to five years and is classified as
bullous or nonbullous (Table 1). The nonbul-
lous type predominates and presents with an
erosion (sore), cluster of erosions, or small
vesicles or pustules that have an adherent or
oozing honey-yellow crust. The predilection
for the very young can be remembered by the
common lay misnomer, “infant tigo.”
Impetigo usually appears in areas where there
FIGURE 5. Ruptured bullous impetigo. is a break in the skin, such as a wound, herpes
simplex infection, or maceration associated
with angular cheilitis (Figure 4), but Staphylo-
with perianal cellulitis found a mean age of coccus aureus can directly invade the skin and
onset of 4.25 years. Ninety percent of patients cause a de novo infection.6
presented with dermatitis, 78 percent with The bullous form of impetigo presents as a
itching, 52 percent with rectal pain, and 35 large thin-walled bulla (2 to 5 cm) containing
percent with blood-streaked stools. Despite 10 serous yellow fluid. It often ruptures leaving a
days of oral antibiotics (primarily penicillin or complete or partially denuded area with a ring
erythromycin), the recurrence rate was high at or arc of remaining bulla (Figure 5). More
39 percent. If there is recurrence, the presence than one area may be involved and a mix of
of an abscess should be considered, with nee- bullous and nonbullous findings can exist.
JULY 1, 2002 / VOLUME 66, NUMBER 1 www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 121
Studies now indicate that both forms of impetigo are primar-
ily caused by Staphylococcus aureus with Streptococcus usu-
ally being involved in the nonbullous form.
122 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 66, NUMBER 1 / JULY 1, 2002
Skin Infections
JULY 1, 2002 / VOLUME 66, NUMBER 1 www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 123
Skin Infections
lococcus and Streptococcus species. Antibi- 9. Barone SR, Aiuto LT. Periorbital and orbital cellulitis
in the Haemophilus influenzae vaccine era. J Pedi-
otics are used empirically with consideration atr Ophthalmol Strabismus 1997;34:293-6.
for resistance patterns. Current antibiotic rec- 10. Ambati BK, Ambati J, Azar N, Stratton L, Schmidt
ommendations include penicillinase-resistant EV. Periorbital and orbital cellulitis before and after
the advent of Haemophilus influenzae type B vac-
penicillins, first-generation cephalosporins, cination. Ophthalmology 2000;107:1450-3.
azithromycin, clarithromycin, amoxicillin- 11. Weiss A, Friendly D, Eglin K, Chang M, Gold B.
clavulanic acid, or a second-generation fluoro- Bacterial periorbital and orbital cellulitis in child-
hood. Ophthalmology 1983;90:195-203.
quinolone in the skeletally mature patient. 12. Martin-Hirsch DP, Habashi S, Hinton AH, Kotecha B.
Gram-negative coverage with a second-, Orbital cellulitis. Arch Emerg Med 1992;9:143-8.
third-, or fourth-generation cephalosporin is 13. Kokx NP, Comstock JA, Facklam RR. Streptococcal
perianal disease in children. Pediatrics 1987;80:
usually indicated in children under three years 659-63.
and in patients with diabetes or who are 14. Brook I. Microbiology of perianal cellulitis in chil-
immunocompromised. dren: comparison of skin swabs and needle aspira-
tion. Int J Dermatol 1998;37:922-4.
The photographs in Figures 1, 2, 4, and 5 were pro- 15. Chartier C, Grosshans E. Erysipelas: an update. Int
J Dermatol 1996;35:779-81.
vided by Utah Valley Family Practice Residency,
16. Barton LL, Friedman AD. Impetigo: a reassessment
Provo, Utah. The photographs in Figures 3 and 6 of etiology and therapy. Pediatr Dermatol 1987;
were provided by Richard Usatine, M.D., of the Uni- 4:185-8.
versity of California-Los Angeles, Los Angeles, Calif. 17. Misko ML, Terracina JR, Diven DG. The frequency
of erythromycin-resistant Staphylococcus aureus in
The authors indicate that they do not have any con- impetiginized dermatoses. Pediatr Dermatol 1995;
flicts of interest. Sources of funding: none reported. 12:12-5.
18. Edlich RF, Horowitz JH, Nichter LS, Silloway KA,
REFERENCES Morgan RF. Clinical syndromes caused by staphylo-
coccal epidermolytic toxin. Compr Ther 1985;11:
1. Elixhauser A, Steiner CA. Most common diagnoses 45-8.
and procedures in U.S. community hospitals, 1996, 19. McLinn S. A bacteriologically controlled, random-
summary. HCUP Research Note. Agency for Health ized study comparing the efficacy of 2% mupirocin
Care Policy and Research, Rockville, Md. Retrieved ointment (Bactroban) with oral erythromycin in the
August 2001, from: www.ahrq.gov/data/hcup/ treatment of patients with impetigo. J Am Acad
commdx/commdx.htm. Dermatol 1990;22(5 pt 1):883-5.
2. Kielhofner MA, Brown B, Dall L. Influence of under- 20. Kiani R. Double-blind, double-dummy comparison
lying disease process on the utility of cellulitis nee- of azithromycin and cephalexin in the treatment of
dle aspirates. Arch Intern Med 1988;148:2451-2. skin and skin structure infections. Eur J Clin Micro-
3. Leppard BJ, Seal DV, Colman G, Hallas G. The value biol Infect Dis 1991;10:880-4.
of bacteriology and serology in the diagnosis of 21. Lentino JR, Augustinsky JB, Weber TM, Pachucki
cellulitis and erysipelas. Br J Dermatol 1985; CT. Therapy of serious skin and soft tissue infec-
112:559-67. tions with ofloxacin administered by intravenous
4. Epperly TD. The value of needle aspiration in the and oral route. Chemotherapy 1991;37:70-6.
management of cellulitis. J Fam Pract 1986;23: 22. Sanjad S, Tolaymat A, Whitworth J, Levin S. Acute
337-40. glomerulonephritis in children: a review of 153
5. Gilbert DN, Moellering RC, Sande MA. The Sanford cases. South Med J 1977;70:1202-6.
guide to antimicrobial therapy 2000. 30th ed. 23. Raz R, Miron D, Colodner R, Staler Z, Samara Z,
Hyde Park, Vt.: Antimicrobial Therapy, 2000:39. Keness Y. A 1-year trial of nasal mupirocin in the
6. Trubo R, Bisno AL, Hacker SM, Roaten SP Jr. Today’s prevention of recurrent staphylococcal nasal colo-
strategies for bacterial skin infections. Patient Care nization and skin infection. Arch Intern Med
1997;31:78-94. 1996;156:1109-12.
7. Olszewski WL. Episodic dermatolymphangioadeni- 24. Jaworsky C, Gilliam AC. Immunopathology of the
tis (DLA) in patients with lymphedema of the lower human hair follicle. Dermatol Clin 1999;17:561-8.
extremities before and after administration of ben- 25. Sadick NS. Current aspects of bacterial infections
zathine penicillin: a preliminary study. Lymphology of the skin. Dermatol Clin 1997;15:341-9.
1996;29:126-31. 26. Ortonne JP. Oral isotretinoin treatment policy. Do we
8. Schwartz GR, Wright SW. Changing bacteriology all agree? Dermatology 1997;195(suppl 1):34-40.
of periorbital cellulitis. Ann Emerg Med 1996; 27. Stone SP. Unusual, innovative, and long-forgotten
28:617-20. remedies. Dermatol Clin 2000;18:323-38.
124 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 66, NUMBER 1 / JULY 1, 2002